More News

24 Mar 2017 PureTech Health Announces Licensing and Equity Agreement with Novartis to Advance Clinical Stage mTORC1 Programs
24 Mar 2017 C4 Therapeutics and Calico Enter Strategic Partnership to Discover Novel Therapeutics Based on Targeted Protein Degradation
24 Mar 2017 BioLineRx Announces Acquisition of Agalimmune Ltd. to Accelerate Expansion of Immuno-Oncology Pipeline
24 Mar 2017 Tessa Therapeutics Announces Acquisition of Euchloe Bio
21 Mar 2017 X-Chem and Ono Enter into Multi-Target Drug Discovery Collaboration
21 Mar 2017 Pierre Fabre and H-Immune Announce Strategic Research Partnership to Develop Potentially Ground-Breaking Cancer Immunotherapies
20 Mar 2017 X-Chem Announces Strategic Collaboration with Astellas Pharma Across Multiple Therapeutic Areas
20 Mar 2017 Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody™ Therapeutics for the Treatment of Cancer and Other Diseases
17 Mar 2017 Threshold Pharmaceuticals and Molecular Templates Agree to Combine
17 Mar 2017 Provecs Medical closes immuno-oncology collaboration with Medac
17 Mar 2017 BELLUS Health Announces the Sale of Subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals
17 Mar 2017 AstraZeneca and Circassia enter strategic collaboration in respiratory disease
16 Mar 2017 Medicenna BioPharma Announces Strategic Collaboration with MD Anderson Cancer Center to Advance Next Generation Empowered Cytokines
14 Mar 2017 Vedantra Pharmaceuticals Announces a Joint Research Collaboration with Neon Therapeutics to Develop Cancer Vaccines
14 Mar 2017 Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases
14 Mar 2017 New Survey Reveals Impact Of Double Chin On Self-Perception And Behavior
14 Mar 2017 AMO Pharma Enters into Collaboration Agreement with Ranedis Pharmaceuticals for Development of RND-001
14 Mar 2017 Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin®
13 Mar 2017 Daiichi Sankyo Enters Agreement with Heptares Therapeutics to Discover and Develop Novel, Small-Molecules for the Treatment of Pain
07 Mar 2017 Cyclenium Pharma Announces a Research Collaboration with The Hospital for Sick Children to Identify Novel Macrocyclic Modulators for Pharmacological Targets in Multiple Therapeutic Areas
07 Mar 2017 Staten Biotechnology exercises option to develop therapeutic SIMPLE AntibodyTM for dyslipidemia from argenx N.V.
07 Mar 2017 Vertex to Acquire CTP-656 from Concert Pharmaceuticals for the Treatment of Cystic Fibrosis
03 Mar 2017 NEMUS Bioscience and Catalent to Advance NB1222 into Human Dosage Formulation Development
03 Mar 2017 Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers
03 Mar 2017 Otsuka Pharmaceutical to Acquire Neurovance, Inc.

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing